Bookmark

Add to MyYahoo RSS

Alexion Pharmaceuticals News

News on Alexion Pharmaceuticals (Ticker: ALXN) continually updated from thousands of sources around the net.

9 hrs ago | Freshnews

Alexion Announces the Appointment of John T. Mollen to Its Board of Directors

Alexion Pharmaceuticals, Inc. today announced the appointment of John "Jack" T. Mollen to the Company's Board of Directors, effective immediately.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Taligen Therapeutics, Computers, EMC, Saint John Fisher College, Rochester, NY

Mon Apr 14, 2014

BioSpace

Alexion Pharmaceuticals Inc. Release: Researchers To Present New Data ...

Alexion Pharmaceuticals Inc. Release: Researchers To Present New Data On Asfotase Alfa In Infants And Juveniles With Hypophosphatasia At The Joint Meeting Of The Pediatric Academic Societies And The Asian Society For Pediatric Research Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present new data from the ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Fri Apr 11, 2014

Customer Interaction Solutions

Researchers to Present New Data on Asfotase Alfa in Infants and...

Alexion Pharmaceuticals, Inc. today announced that researchers are scheduled to present new data from the extension phase of two clinical studies examining the long-term efficacy and safety of asfotase alfa in infants and juveniles with hypophosphatasia at the joint meeting of the Pediatric Academic Societies and the Asian Society for Pediatric ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Genetics

Thu Apr 10, 2014

WTSP-TV Saint Petersburg

Nasdaq's worst swoons since 2011 puts investors on edge

Investors whacked biotech and tech stocks leading the Nasdaq to its deepest percentage slump since November 2011 and the broader market gave in to selling pressure as well, wiping away all of the previous two-day rally.

Comment?

Related Topix: Financial Markets, Startups, Facebook, Biotech, Taligen Therapeutics, Medicine, Healthcare Industry

The Motley Fool

Why Alexion Pharmaceuticals, Gilead Sciences, and Monster Beverage...

After about seven out of every 10 stocks added ground yesterday, I opened my evening article with a simple sentence: "It was tough ," I said, "to lose money in the stock market today."

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Taligen Therapeutics, Financial Markets, Hansen Natural, Beverages, Monster Worldwide, Human Resources, Advertising

Silicon Alley Insider

Biotech Stocks Are Getting Smashed

Among the big losers are Alexion Pharmaceuticals , Gilead Sciences , Biogen Idec , and Vertex Pharmaceuticals .

Comment?

Related Topix: Biotech, Taligen Therapeutics, Medicine, Healthcare Industry, Startups, Gilead Sciences, CGI Pharmaceuticals

Silicon Alley Insider

Stocks Crumbling

U.S. stocks have taken a sharp turn lower today as the Japanese yen strengthens against the U.S. dollar.

Comment?

Related Topix: Financial Markets, Biotech, Taligen Therapeutics, Medicine, Healthcare Industry

BioSpace

Alexion Pharmaceuticals Inc. To Report First Quarter 2014 Results On Thursday, April 24, 2014

Alexion Pharmaceuticals, Inc. today announced that the Company will report its financial results for the first quarter ended March 31, 2014 on Thursday, April 24, 2014 before the US financial markets open.

Comment?

Related Topix: Taligen Therapeutics, Biotech, Medicine, Healthcare Industry

Fri Apr 04, 2014

Reuters

Momentum names may see more pain

After their worst week in several years, high-flying stocks that defied gravity throughout 2013 look like they're in for more punishment.

Comment?

Related Topix: Financial Markets, Biotech, Science / Technology, Cloud Computing, US Global Investors, Financial Services, Investment Services, Taligen Therapeutics, Medicine, Healthcare Industry

Iol.co.za

Nasdaq drops 1% as momentum names drop

The Nasdaq fell 1 percent on Friday, reversing earlier gains as shares of some of the index's biggest recent out-performers dropped dramatically.

Comment?

Related Topix: Startups, Intuitive Surgical, Biotech, Taligen Therapeutics, Medicine, Healthcare Industry

Thu Apr 03, 2014

AmericanBankingNews.com

Alexion Pharmaceuticals Receives Average Rating of "Buy" from Analysts

Shares of Alexion Pharmaceuticals have been given an average recommendation of "Buy" by the nineteen analysts that are presently covering the company, AmericanBankingNews.com reports .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Taligen Therapeutics

Thu Mar 27, 2014

AmericanBankingNews.com

Alexion Pharmaceuticals Price Target Increased to $171.00 by Analysts at Credit Suisse

The firm currently has a "neutral" rating on the stock. Credit Suisse's price target points to a potential upside of 13.58% from the company's current price.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Taligen Therapeutics

Tue Mar 25, 2014

MarketNewsVideo

Nasdaq 100 Movers: WFM, ALXN

In early trading on Tuesday, shares of Alexion Pharmaceuticals topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.9%.

Comment?

Related Topix: Biotech, Taligen Therapeutics, Medicine, Healthcare Industry, Retail, Whole Foods Market, Grocery, 38 Studios, Video

The Washington Post

U.S. Stocks Drop on Slowing Factory Data as Biotech Shares Slump

U.S. stocks fell for a second day as economic data signaled a slowdown in American manufacturing and some banks said Russia's economy will enter a recession.

Comment?

Related Topix: Financial Markets, Science / Technology, Biotech, Medicine, Healthcare Industry, Overland Park, KS, Park, KS, Netherlands, World News

Mon Mar 24, 2014

The Motley Fool

Why Netflix, Alexion Pharmaceuticals, and Facebook Are Today's 3 Worst Stocks

Eight in 10 sectors saw declines on Monday, as heavy selling among high-growth stocks and recent outperformers brought the broader market down as well.

Comment?

Related Topix: Startups, Financial Markets, Facebook, Biotech, Taligen Therapeutics, Medicine, Healthcare Industry

Barron's

S&P 500 Drops: Blame Mondays?

Stocks fell today despite the lack of anything significant that would drive down the prices of Netflix , Alexion Pharmaceuticals and Facebook , among other high fliers.

Comment?

Related Topix: Financial Markets, Biotech, Taligen Therapeutics, Medicine, Healthcare Industry, IBM

Silicon Alley Insider

Biotech Stocks Are Making That Hissing Sound Again

Biotech stocks are in the red, with the iShares Biotechnology Index down by 2.6% early in the U.S. trading session.

Comment?

Related Topix: Biotech, Science / Technology, Financial Markets, Taligen Therapeutics, Medicine, Healthcare Industry, Startups, Gilead Sciences, CGI Pharmaceuticals

Barron's

Stocks Fall as Global Economic Activity Weakens; Risk to the Downside?

The stock market has dropped today as global economic disappointed and investors abandon some of the market's highest-flying stocks, including Netflix , Alexion Pharmaceuticals , Facebook , Mylan and Michael Kors .

Comment?

Related Topix: Financial Markets, Biotech, Taligen Therapeutics, Medicine, Healthcare Industry, Pharmaceuticals, Mylan Laboratories, Apparel, Michael Kors

Forbes.com

Nasdaq 100 Movers: ALXN, SYMC

In early trading on Monday, shares of Symantec topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.2%.

Comment?

Related Topix: Startups, Symantec, Biotech, Taligen Therapeutics, Medicine, Healthcare Industry, Financial Markets

Fri Mar 21, 2014

The Motley Fool

Why Symantec Corporation, Biogen Idec, and Alexion Pharmaceuticals Are Today's 3 Worst Stocks

Then it steadily declined for the remainder of the day, driven by a slumping health-care sector.

Comment?

Related Topix: Startups, Symantec, Biotech, Taligen Therapeutics, Medicine, Healthcare Industry, Biogen Idec

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••